Is Linde (LIN) overvalued or fairly valued?

MarketChacha shows Linde's valuation in context — a trailing P/E of about 29.9, a forward P/E of about 24.4, a price-to-book of about 5.6 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does Linde's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (1.48×) from reported figures — education, not a rating.

What is Linde's revenue?

Linde reported revenue of $34.0B for FY2025, with net profit of $6.9B, per official filings.

What is the share price of Linde (LIN)?

Linde last traded at $477.57 (-1.0% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Linde

LIN · NASDAQ · Chemicals · United States

Snapshot

TickerLIN

ExchangeNASDAQ

SectorChemicals

IndustrySpecialty Chemicals

CountryUnited States

Employees64,649

HeadquartersWoking, United Kingdom

Websitewww.linde.com

Filings tracked17

About Linde

Linde plc operates as an industrial gas company worldwide. The company offers atmospheric gases, including oxygen, nitrogen, argon, and rare gases; and process gases, such as hydrogen, helium, carbon dioxide, carbon monoxide, electronic gases, specialty gases, and acetylene. It also engages in the design and construction of turnkey process plants for third-party customers, as well as for its gas businesses, including air separation, hydrogen, synthesis, olefin, and natural gas plants. The company serves the healthcare, chemicals and energy, manufacturing, metals and mining, food and beverage, and electronics industries. It operates in the United States, Brazil, Mexico, Canada, Germany, the United Kingdom, Eastern Europe, China, Australia, South Korea, and India. Linde plc was founded in 1879 and is based in Woking, the United Kingdom.

Who owns it

Insiders0.2%
Institutions88.8%
Public & other10.9%

3,371 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.7.69%
Vanguard Capital Management LLC6.23%
State Street Corporation4.20%
Capital Research Global Investors3.59%
Invesco Ltd.3.16%
Vanguard Portfolio Management LLC2.57%
Geode Capital Management, LLC2.46%
Price (T.Rowe) Associates Inc2.44%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion1.48×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend18.9% → 20.3%

Margin has expanded by about 1.4 points — the business is getting more profitable.

Return on equity18.0%

Latest ROE of 18.0% — capital is generating a healthy return.

Growth qualityrev 2% · PAT 5%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $9.2B · EPS 4.30

Est. earnings growth +7.8%

Next fiscal year

Rev $38.0B · EPS 18.25

Est. earnings growth +9.4%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$34.0B

Net margin

20.3%

ROE

18.0%

Revenue CAGR (2y)

+1.7%

Profit CAGR (2y)

+5.5%

EPS (FY2025)

14.61

Net profit (FY2025)

$6.9B

Ask MarketChacha about LIN

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$34.0B	$6.9B	14.61	20.3%	18.0%
FY2024	$33.0B	$6.6B	13.62	19.9%	17.2%
FY2023	$32.9B	$6.2B	12.59	18.9%	15.6%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$9.3B	$1.9B	4.15	20.8%
2026Q1	$8.8B	$1.9B	3.98	21.1%
2025Q3	$8.6B	$1.9B	4.09	22.4%
2025Q2	$8.5B	$1.8B	3.73	20.8%
2025Q1	$8.1B	$1.7B	3.51	20.6%
2024Q3	$8.4B	$1.6B	3.22	18.5%
2024Q2	$8.3B	$1.7B	3.44	20.1%
2024Q1	$8.1B	$1.6B	3.35	20.1%
2023Q3	$8.2B	$1.6B	3.19	19.2%
2023Q2	$8.2B	$1.6B	3.19	19.2%
2023Q1	$8.2B	$1.5B	3.06	18.5%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

10-Q filing
SEC7/31/2026
8-K — Results of operations, Exhibits
SEC7/31/2026material
8-K — Shareholder vote results, Exhibits
SEC7/30/2026material
8-K — Other events, Exhibits
SEC5/13/2026material
8-K — Results of operations, Exhibits
SEC5/1/2026material
10-Q filing
SEC5/1/2026
10-K filing
SEC2/25/2026
8-K — Results of operations, Exhibits
SEC2/5/2026material

2025

8-K — Material agreement, Material financial obligation, Exhibits
SEC12/3/2025material
8-K — Other events, Exhibits
SEC11/20/2025material
8-K — Results of operations, Exhibits
SEC10/31/2025material
10-Q filing
SEC10/31/2025
8-K — Executive/director change, Exhibits
SEC9/29/2025material
8-K — Executive/director change, Exhibits
SEC8/7/2025material
8-K — Results of operations, Exhibits
SEC8/1/2025material
10-Q filing
SEC8/1/2025
8-K — Shareholder vote results, Exhibits
SEC8/1/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.